Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $926.65 | 31 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $366.79 | 16 | $0 (2024) |
| REVANCE THERAPEUTICS, INC. | $249.01 | 5 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $156.67 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $60.78 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $39.40 | 1 | $0 (2024) |
| Phadia US Inc. | $20.85 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $17.62 | 1 | $0 (2023) |
| LEO Pharma Inc. | $15.53 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $417.64 | 13 | REVANCE THERAPEUTICS, INC. ($249.01) |
| 2023 | $377.28 | 12 | GENZYME CORPORATION ($222.31) |
| 2022 | $109.02 | 5 | GENZYME CORPORATION ($88.17) |
| 2021 | $22.71 | 1 | GENZYME CORPORATION ($22.71) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/27/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Immunology | ||||||
| 08/16/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 08/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
| 05/30/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $53.93 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 05/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $39.40 | General |
| Category: Immunology | ||||||
| 04/25/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $15.92 | General |
| 03/20/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 02/27/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Immunology | ||||||
| 01/31/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 10/05/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: Dermatology | ||||||
| 10/05/2023 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $11.40 | General |
| 10/02/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $37.43 | General |
| 09/18/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $39.65 | General |
| 08/21/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $22.99 | General |
| 07/11/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $6.14 | General |
| 05/31/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $39.74 | General |
| 05/15/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $18.51 | General |
| 05/03/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $39.84 | General |
| 04/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/02/2023 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $6.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 76 | 81 | $15,713 | $3,864 |
| 2022 | 6 | 108 | 208 | $19,133 | $7,347 |
| 2021 | 5 | 101 | 136 | $16,915 | $7,266 |
| 2020 | 5 | 78 | 105 | $11,618 | $5,528 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 24 | $5,097 | $1,340 | 26.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 13 | $2,640 | $840.20 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 18 | $2,987 | $636.42 | 21.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,033 | $573.96 | 18.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 15 | 15 | $1,956 | $473.69 | 24.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 39 | $6,775 | $2,735 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,420 | $1,670 | 48.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 17 | $2,632 | $1,140 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 27 | $3,627 | $991.90 | 27.3% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 11 | 92 | $938.30 | $420.59 | 44.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 14 | 17 | $1,742 | $389.11 | 22.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 52 | $6,032 | $2,365 | 39.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 19 | 28 | $3,994 | $2,073 | 51.9% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 23 | 23 | $3,202 | $1,607 | 50.2% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 14 | 16 | $2,176 | $762.73 | 35.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 17 | $1,511 | $459.58 | 30.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 32 | $4,048 | $1,954 | 48.3% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 15 | 19 | $2,534 | $1,187 | 46.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 24 | $2,095 | $1,054 | 50.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 13 | 13 | $1,630 | $765.74 | 47.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 13 | 17 | $1,311 | $568.09 | 43.3% |
About Britney Kaufman, PA
Britney Kaufman, PA is a Physician Assistant healthcare provider based in Ontario, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1255500724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Britney Kaufman, PA has received a total of $926.65 in payments from pharmaceutical and medical device companies, with $417.64 received in 2024. These payments were reported across 31 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($926.65).
As a Medicare-enrolled provider, Kaufman has provided services to 363 Medicare beneficiaries, totaling 530 services with total Medicare billing of $24,005. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Other Specialties Dermatology
- Location Ontario, CA
- Active Since 02/28/2008
- Last Updated 11/14/2023
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1255500724
Products in Payments
- DAXXIFY (Drug) $249.01
- DUPIXENT (Biological) $174.35
- TREMFYA (Drug) $60.78
- Sotyktu (Drug) $39.40
- ImmunoCAP (Device) $20.85
- COSENTYX (Drug) $17.62
- ADBRY (Biological) $15.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Ontario
Miss. Amanda Vansant, Pa-C, PA-C
Physician Assistant — Payments: $10,212
Stephen Brown, Msbs, Pa-C, MSBS, PA-C
Physician Assistant — Payments: $4,301
Miss. Courtney Kinholt, Pa-C, PA-C
Physician Assistant — Payments: $3,368
Charles Davis, Pa, PA
Physician Assistant — Payments: $1,472
Lauren Kauffman, Pa-C, PA-C
Physician Assistant — Payments: $757.48
Linden Batiste, Pac, PAC
Physician Assistant — Payments: $606.36